PERK通路调节对结直肠癌管理的重要性:系统性审查
Marzieh Nemati1, Sanaz Dastghaib2,3, Zahra Hosseinzadeh2
1Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
BMC cancer
|October 3, 2025
概括
结直肠癌中的蛋白质激酶RNA类内质网膜激酶 (PERK) 途径具有双重作用,有时抑制瘤生长,有时促进瘤生长. 了解这种上下文依赖的功能是开发有效的PERK向疗法的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞应激反应的应激反应
背景情况:
- 蛋白质激酶RNA类内质网膜激酶 (PERK) 途径是未折叠蛋白质反应 (UPR) 的关键组成部分.
- 在结直肠癌 (CRC) 中PERK的作用是复杂的,研究表明瘤抑制和瘤促进作用.
- 这种复杂性需要进行彻底的审查,以了解PERK在CRC进展中的双重作用.
研究的目的:
- 系统地审查和澄清PERK信号在结直肠癌 (CRC) 中的双重作用.
- 评估PERK信号传导作为CRC治疗点的潜力.
主要方法:
- 全文英语语言研究的系统审查.
- 包括使用体外和/或动物CRC模型的研究.
- 排除对非CRC恶性瘤或无关机制的研究.
- 在PubMed,科学网和Scopus进行的搜索.
主要成果:
- 在对395篇文章进行初步选后,有45项研究符合纳入标准.
- 大多数研究 (36/45) 使用了体外模型,HCT-116细胞是常见的.
- 虽然36项研究报告了PERK激活的抗瘤效应,但在特定条件下,有几个研究指出了促进瘤的潜力.
- 相互矛盾的结果可能源于实验模型,PERK调制和应力诱导方法的变化.
结论:
- 在CRC中PERK通路的激活表现出一种双重的,取决于背景的性质.
- PERK经常表现出瘤抑制作用,但也可以促进瘤生长.
- 对PERK的多方面的作用有细微的理解对于设计有针对性的CRC疗法至关重要.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
14.3K
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
900
相关概念视频
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
